BRISTOL MYERS SQUIBB CO (BMY)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 12,269 | 11,201 | 11,892 | 12,201 |
| Selling, general and administrative | 1,713 | 1,584 | 1,983 | 1,928 |
| Research and development | 2,580 | 2,257 | 2,374 | 2,899 |
| Other (income)/expense, net | -494 | -339 | -234 | -273 |
| Cost of products sold | 3,372 | 3,033 | 2,957 | 3,267 |
| Amortization of acquired intangible assets | 830 | 830 | 2,406 | 2,416 |
| Acquired iprd | 1,508 | 188 | 262 | 132 |
| Total expenses | 10,496 | 8,230 | 10,216 | 10,915 |
| Earnings/(loss) before income taxes | 1,773 | 2,971 | - | - |
| Income tax provision/(benefit) | 460 | 509 | 461 | -398 |
| Earnings/(loss) before income taxes | - | - | 1,676 | 1,286 |
| Net earnings/(loss) | 1,313 | 2,462 | 1,215 | 1,684 |
| Noncontrolling interest | 2 | 6 | 4 | 4 |
| Net earnings/(loss) attributable to bms | 1,310 | 2,456 | 1,211 | 1,680 |
| Basic (usd per share) | 0.64 | 1.21 | 0.6 | 0.83 |
| Diluted (usd per share) | 0.64 | 1.2 | 0.6 | 0.83 |
| Weighted-average common shares outstanding basic (in shares) | 2,035,000,000 | 2,031,000,000 | 2,028,000,000 | 2,027,000,000 |
| Weighted-average common shares outstanding diluted (in shares) | 2,038,000,000 | 2,040,000,000 | 2,031,000,000 | 2,029,000,000 |